The National Agency for Food and Drug Administration and Control (NAFDAC) has discontinued the registration of Multi-Dose Anti-Malarial (Artemether/Lumefantrine) dry powder for oral suspension.
Trending
- Study finds strongest evidence that shingles vaccine reduces dementia risk
- Nintendo to launch Switch 2 console on June 5
- Amazon makes last-minute bid for TikTok — Report
- Hungarian govt to support Sokoto in agriculture, health, other sectors
- I will not become a thief because of you – Joshua Gana tells Constituents
- National Park advocates carbon reduction for climate action
- Disease prevention: L-PRES to establish 20 veterinary hospitals
- Tinubu reconstitutes NNPC’s board, appoints new CEO
